Initial focused sequencing studies on MCC identified recurrent mutations including TP53 and RB1 in a subset of tumors but did not correlate these findings with MCPyV or global mutation changes (54, 155–159). This evidence concerns the gene RB1 and Merkel cell skin cancer.